Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. - Wikidata - awgldk - TriplyDB

Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids.

Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids.

http://www.wikidata.org/entity/Q33896072

about

Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon HBV pathogenesis in animal models: recent advances on the role of platelets Adaptive immunity in the liver Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus Particles Efficacy of cationic lipid–DNA complexes (CLDC) on hepatitis B virus in transgenic mice Molecular biology of hepatitis B virus infection Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.The Role of cccDNA in HBV Maintenance.Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice.Pathogenesis of hepatitis B virus infection Antibody responses during hepatitis B viral infection.Inhibition of hepatitis B virus replication by MyD88 involves accelerated degradation of pregenomic RNA and nuclear retention of pre-S/S RNAs.Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells.Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein.Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injection Animal models and the molecular biology of hepadnavirus infection Inhibition of hepatitis B virus replication by cIAP2 involves accelerating the ubiquitin-proteasome-mediated destruction of polymerase.Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus The role of cells refractory to productive infection in acute hepatitis B viral dynamics.Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue.The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B Molecular virology of hepatitis B virus for clinicians.Hepatic deficiency of the pioneer transcription factor FoxA restricts hepatitis B virus biosynthesis by the developmental regulation of viral DNA methylation Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells Hepatitis B virus replication and release are independent of core lysine ubiquitination HBV replication is significantly reduced by IL-6.The role of tumour necrosis factor in hepatitis B infection: Jekyll and Hyde.Control of Hepatitis B Virus by Cytokines Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro.

P2860

Q24306639-83F7F507-2AFC-41DA-AC65-CC074C1E0412 Q24672103-B5F78906-448B-40BC-82BC-ABB755FBB290 Q26753195-4535B1C1-F269-4B7E-8BC0-EAA810DCA830 Q27318089-870D6BCE-CB8A-4DB5-A3BE-5DE36DF20768 Q27477620-F9E8F7E9-84DC-4857-A1B1-432596A44CF4 Q27486380-6C53C91C-D9EC-4695-9D77-CA4E92026CEC Q28083478-73CAFF98-F1C6-4113-9C21-F0FA8BC527E9 Q28742762-BAB08035-3632-4639-AE5B-06069DA27BDB Q32182914-F1CBDF7E-BF76-4D64-A748-00A9BF87ED80 Q33807794-731DE7BE-734C-4998-9C46-459B7C10FDF4 Q33925491-EB1702C2-FBA9-4516-812A-A78A74F47CC4 Q33981600-E54395E4-A659-47FC-B314-AAF872C2350B Q33990530-C6047296-F872-4966-A025-3554AD38FE30 Q34120253-7A23197F-88FA-4633-80F1-AAA14B107C08 Q34137297-4E8EE2F3-4A26-4E94-8959-A7F474A2393B Q34262225-40001FCA-6821-49F9-B351-9FC46BF280A6 Q34485130-9E7E578E-7AFD-4613-9334-EB73AD5F8903 Q34819738-4CEA767E-CE2F-429D-9350-D1183ACD0607 Q34998226-9035752B-9CDA-4C28-BE20-88DCEFE2C68E Q35008279-C3DA3E38-A60C-4775-9BCC-61D9AF459125 Q35117727-86B7ED34-2DCB-4FF6-9ABE-79DE5F326271 Q35245221-0DDF7F18-9F3D-4289-B7E2-E7D9A0459968 Q35362817-9FB6642C-976D-406F-AD24-5F2B91E281FF Q35634949-C4A8C969-6C70-4E72-8C02-507FB9925FF3 Q35691056-71132397-BDB1-4557-A60C-B6C0E3EE768C Q35850262-E64F5CAF-2257-405F-9FE9-9C5385D5C578 Q35973592-144C6D30-74CB-401A-8CD1-763F336DF045 Q36099079-1E2446B7-EB19-47B0-9DE2-10ECBDB15225 Q36110296-7B92E212-7509-4C7A-A684-BFFAD43F52AB Q36282234-865BAA09-7B58-4DBE-A122-94F997FF33FD Q36290098-E00E1581-52F3-44ED-A50C-16677918DEB5 Q36614504-D715D339-EF43-4EBE-84C2-312A7E5A7303 Q36747910-0565C6A4-1EE1-4B64-9D99-0ABC87E65974 Q37033361-041C1559-BA43-46B9-A55C-7FF882ED7C89 Q37192164-04138D71-BDA6-4E06-8EAB-673DE24754ED Q37204748-552AD1BD-B8D4-4A0E-AC49-61B6B6D41CCA Q37538505-6BB695A4-4D96-4B9F-93B4-A50BDE165FFA Q37628224-A46BE3A5-E8CB-4C6E-9EBC-77721D326211 Q37644059-BC28C06E-CAB3-4734-A0C5-A4E97EEBFA7C Q37711751-6E1B2283-8852-4DCA-B060-B6939F12B1A0

P2860

Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids.

http://www.wikidata.org/entity/Q33896072

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Interferon prevents formation ...... RNA-containing nucleocapsids.

@ast

Interferon prevents formation ...... RNA-containing nucleocapsids.

@en

type

label

Interferon prevents formation ...... RNA-containing nucleocapsids.

@ast

Interferon prevents formation ...... RNA-containing nucleocapsids.

@en

prefLabel

Interferon prevents formation ...... RNA-containing nucleocapsids.

@ast

Interferon prevents formation ...... RNA-containing nucleocapsids.

@en

P1433

Q33896072-7080FC1E-A51A-4E7A-AAAC-310FB248C9C0

P1476

Q33896072-B9034185-495B-4AFB-A349-235E34A0ED56

P2093

Q33896072-3F4D69C3-C525-4195-B7B8-79A91BD8D425

Q33896072-62013902-A223-43C7-96D7-40C02F9665D9

Q33896072-758DD468-6888-4D71-B661-CF603A7CCFC1

Q33896072-CE9D15E8-5105-4719-9E01-EC5BDA509CD0

P2860

Q33896072-074D5993-641D-4077-8CEF-07EB77054E19

Q33896072-0936DFB6-B66B-4A40-8B06-F7B7B51421F9

Q33896072-0E0D48ED-1AFC-4F50-BAAE-E3088E6D637A

Q33896072-15337CF3-7AC1-4542-80DC-00ED9CE99181

Q33896072-268C81C2-29B1-46F9-AE8A-7CFE9504F5E9

Q33896072-2DA3F485-1DBA-434D-A004-55B200E76D18

Q33896072-2F54A2BD-177A-4E7A-BD3F-D076810F5680

Q33896072-305DE0B8-F788-4A46-97CA-2FCF5A8CB886

Q33896072-308CECE4-837B-4F0B-B765-4361E57A0AC1

Q33896072-33E44EAB-748A-40D2-B49F-548CB63E1943

P304

Q33896072-DEF1DCF0-A364-451D-BC32-C5A258211A6D

P31

Q33896072-6A04FF99-47E6-465C-90AF-3FC3D30D3491

P356

Q33896072-EF7D6AEF-0D62-4C43-B974-3A3ACC477B07

P407

Q33896072-F39309FA-B05C-49AA-82F8-9A63839DAF7B

P433

Q33896072-48240070-54A7-463C-99E2-E8E9088C370A

P478

Q33896072-AC2E036D-75A6-41D2-BE92-6ED321DA2C41

P50

Q33896072-B4482239-0D9F-4DB8-8778-E7B68EB28002

P577

Q33896072-3B16FC3A-0760-41A0-BB05-B3B86FB20983

P5875

Q33896072-4216F263-9FFA-48EE-B8D0-55E23D83FCAF

P698

Q33896072-3FD7FDB2-5369-4E3D-8EAB-018ECAF674A1

P921

Q33896072-126A9F2E-B6F7-47FC-A7EF-DC40078B567A

P932

Q33896072-A8719B46-0B32-446E-9A9C-3E6E7E922AB7

P356

PNAS.0504273102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Interferon prevents formation ...... RNA-containing nucleocapsids.

@en

P2093

Angelina Eustaquio

http://www.w3.org/2001/XMLSchema#string

Bryan Boyd

http://www.w3.org/2001/XMLSchema#string

Christina Whitten-Bauer

http://www.w3.org/2001/XMLSchema#string

Stefan F Wieland

http://www.w3.org/2001/XMLSchema#string

P2860

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

Transcriptional activation by tetracyclines in mammalian cells

Expression of the P-protein of the human hepatitis B virus in a vaccinia virus system and detection of the nucleocapsid-associated P-gene product by radiolabelling at newly introduced phosphorylation sites.

Genomic analysis of the host response to hepatitis B virus infection.

Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice

Reconstitution of a functional duck hepatitis B virus replication initiation complex from separate reverse transcriptase domains expressed in Escherichia coli

Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids.

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen.

P304

9913-9917

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0504273102

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Francis V. Chisari

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7750397

http://www.w3.org/2001/XMLSchema#string

P698

15994231

http://www.w3.org/2001/XMLSchema#string

P921

P932

1175012

http://www.w3.org/2001/XMLSchema#string